Case Study: a leading American biotechnology company achieves 0% defect leakage with Tricentis Tosca

Leading American Biotechnology Company achieves 0% defect leakage with Tricentis Tosca

A leading American biotechnology company faced significant challenges in maintaining software quality across its complex ecosystem of over 35 enterprise applications. With fragmented, manual testing processes, they struggled to keep pace with frequent updates in their highly regulated environment, risking serious compliance issues. They partnered with vendor Tricentis and implemented their product, Tricentis Tosca, to establish a centralized Testing Center of Excellence (TCoE) and create a scalable automation framework.

The solution implemented by Tricentis, delivered with partner Cognizant, involved using Tricentis Tosca's codeless, model-based approach to automate end-to-end testing. This resulted in over 40% test automation, a 0% schedule variance, and the complete elimination of defect leakage into production. The transformation generated over $600,000 in savings and provided real-time reporting capabilities, ensuring compliance and accelerating release cycles without compromising quality.